Landscapes / Companies
Axogen Corporation not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 2 in all
Trials
1 active
2 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | 5 Dec 2030Phase 4 trial completes | |||
| Next date | 5 Dec 2030 · Phase 4 trial completes | ||||
| Also tested for | Peripheral Nerve Injury, Peripheral Nerve Discontinuity and 3 more | ||||
| Open drug page | |||||
About
- No active trial
- Processed Nerve Allograft
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021